Novel cis-regulatory function in ICR-mediated imprinted repression of H19  by Ideraabdullah, Folami Y. et al.
Developmental Biology 355 (2011) 349–357
Contents lists available at ScienceDirect
Developmental Biology
j ourna l homepage: www.e lsev ie r.com/deve lopmenta lb io logyGenomes & Developmental Control
Novel cis-regulatory function in ICR-mediated imprinted repression of H19
Folami Y. Ideraabdullah a,1, Lara K. Abramowitz a,1, Joanne L. Thorvaldsen a, Christopher Krapp a,
Sherry C. Wen a,2, Nora Engel b, Marisa S. Bartolomei a,⁎
a Department of Cell and Developmental Biology, University of Pennsylvania School of Medicine, 415 Curie Boulevard, Philadelphia, PA 19104, USA
b Fels Institute for Cancer Research and Molecular Biology, Temple University School of Medicine, 3307 North Broad Street, Philadelphia, PA 19140, USA⁎ Corresponding author. Fax: +1 215 573 6434.
E-mail address: bartolom@mail.med.upenn.edu (M.S
1 These authors contributed equally to this work.
2 Current address. Department of Microbiology, Vand
Light Hall, Nashville, TN 37232, USA.
0012-1606/$ – see front matter © 2011 Elsevier Inc. Al
doi:10.1016/j.ydbio.2011.04.036a b s t r a c ta r t i c l e i n f oArticle history:
Received for publication 2 March 2011
Revised 25 April 2011
Accepted 30 April 2011
Available online 10 May 2011
Keywords:
Genomic imprinting
H19
DNA methylation
Transcriptional regulation
Imprinted repression
CpG densityExpression of coregulated imprinted genes, H19 and Igf2, is monoallelic and parent-of-origin-dependent. Like
most imprinted genes, H19 and Igf2 are regulated by a differentially methylated imprinting control region
(ICR). CTCF binding sites and DNA methylation at the ICR have previously been identiﬁed as key cis-acting
elements required for proper H19/Igf2 imprinting. Here, we use mouse models to elucidate further the
mechanism of ICR-mediated gene regulation. We speciﬁcally address the question of whether sequences
outside of CTCF sites at the ICR are required for paternal H19 repression. To this end, we generated two types
of mutant ICRs in the mouse: (i) deletion of intervening sequence between CTCF sites (H19ICRΔIVS), which
changes size and CpG content at the ICR; and (ii) CpG depletion outside of CTCF sites (H19ICR-8nrCG), which
only changes CpG content at the ICR. Individually, both mutant alleles (H19ICRΔIVS and H19ICR-8nrCG) show loss
of imprinted repression of paternal H19. Interestingly, this loss of repression does not coincide with a
detectable change in methylation at the H19 ICR or promoter. Thus, neither intact CTCF sites nor
hypermethylation at the ICR is sufﬁcient for maintaining the fully repressed state of the paternal H19 allele.
Our ﬁndings demonstrate, for the ﬁrst time in vivo, that sequence outside of CTCF sites at the ICR is required in
cis for ICR-mediated imprinted repression at the H19/Igf2 locus. In addition, these results strongly implicate a
novel role of ICR size and CpG density in paternal H19 repression.. Bartolomei).
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Genomic imprinting is an epigenetic process resulting inmonoallelic
expression of a subset of mammalian genes. Expression of imprinted
genes is dependent on the parent-of-origin of the allele (Cattanach and
Kirk, 1985). During gametogenesis, parental alleles of imprinted genes
are differentially marked with DNA methylation, which is maintained
throughout development despite genome-wide demethylation in the
preimplantation embryo (Oswald et al., 2000; Tremblay et al., 1997).
Loss of imprinting is often associated with loss of differential methyl-
ation and is implicated inmany human diseases, including several types
of cancers (Gicquel et al., 2005; Sparago et al., 2007; Wu et al., 2006).
Most imprinted genes reside in clusters throughout the genome
(Verona et al., 2003), which allows for coregulation of closely located
genes. One of the ﬁrst identiﬁed and most widely studied clusters is
located on distal mouse chromosome 7 and found in conserved synteny
on human chromosome 11. Located in this region are imprinted genes
H19 (a non-coding RNAof unknown function) and Igf2 (a fetalmitogen),which are expressed from alternate parental alleles but share elements
controlling their imprinted expression (Bartolomei et al., 1991;DeChiara
et al., 1991; Thorvaldsen et al., 1998). Loss of imprinting at this locus
is associated with Beckwith–Wiedemann Syndrome (BWS), an over-
growth syndrome linked to overexpression or biallelic expression of
IGF2 (Cerrato et al., 2008; Sparago et al., 2007); and the reciprocal
disorder, Silver–Russell Syndrome(SRS), a dwarﬁsm syndrome linked to
underexpression or biallelic silencing of IGF2 (Gicquel et al., 2005).
Imprinted expression ofH19 and Igf2 in themouse is regulated by two
key elements: (i) shared enhancers downstream of H19 including those
that control expression in endodermal (Leighton et al., 1995) and
mesodermal (Kaffer et al., 2000, 2001) tissues and (ii) a differentially
methylated imprinting control region (ICR) located between the two
genes,−2 to−4 kb from the H19 transcriptional start site (Thorvaldsen
et al., 1998; Tremblay et al., 1997). Differential methylation at the ICR is
established during germ cell development when parental alleles are
separated. At this time maternal and paternal alleles become hypo- and
hyper-methylated, respectively (Davis et al., 2000; Tremblay et al., 1997).
CTCF binds the hypomethylated maternal ICR at four tandem repetitive
sites (Bell and Felsenfeld, 2000; Hark et al., 2000), establishing an
insulator that blocks Igf2 promoters from interaction with the down-
stream enhancers. This binding prevents maternal Igf2 expression and
allowsmaternalH19expression (Engel et al., 2006;Pant et al., 2003; Szabo
et al., 2004). Conversely, CTCF does not bind to the hypermethylated
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enhancers andsubsequentexpressionofpaternal Igf2 (Bell andFelsenfeld,
2000; Hark et al., 2000).
Previous studies have demonstrated roles for both cis and trans-
acting elements at the ICR in regulation of H19 expression. On the
maternal allele, studies clearly show that binding of CTCF to the ICR is
required for insulation and activation of maternal H19 (Engel et al.,
2006; Schoenherr et al., 2003; Szabo et al., 2004). Less is known about
the regulatory function of the hypermethylated paternal ICR in H19
repression. DNA methylation at the ICR plays a major role in paternal
H19 repression and it has been proposed that the hypermethylated
ICR acts as a center for spreading repressive methylation to the H19
promoter thereby silencing paternal H19 (Thorvaldsen et al., 1998;
Tremblay et al., 1997). Based on in vitro assays, Chen et al. reported
that the positions of CpGs within CTCF binding sites at the ICR are
more important for repression than positions of CpGs outside of CTCF
binding sites (Chen et al., 2009). Furthermore, we showed that
paternal inheritance of a CpG depleted ICR (mutation of 9 CpGs within
CTCF binding sites, H19DMD-9CG) resulted in hypomethylation at the
mutant ICR and biallelic H19 expression (Engel et al., 2004).
In addition to DNAmethylation, in vitro assays as well as mutations
at the endogenous locus provide evidence that the ICR may harbor
other elements that repress H19 expression (Chen et al., 2009;
Drewell et al., 2000; Engel et al., 2004). In particular, a 1.2 kb region
was reported to be a silencer element (Brenton et al., 1999; Lyko et al.,
1997). Deletion of this region on the paternal allele resulted in a loss of
H19 repression without a change in methylation at the ICR in E13.5
embryos (Drewell et al., 2000). This deletion removed two CTCF
binding sites and ~50% of the ICR, containing more than 50% of
methylation sites (CpGs). Therefore, it is not knownwhether size, CpG
content or CTCF binding sites are responsible for this silencer function.
These and other studies clearly demonstrate that cis-acting
elements at the ICR are required for paternal repression. However,
because all reported in vivo mutations that disrupt H19 paternal
repression also disrupted CTCF binding sites, it remains unclear
whether repression is solely dependent upon sequence at CTCF
binding sites, or if sequences outside of CTCF binding sites are also
important in H19 repression. Here, we speciﬁcally investigated the
presence of cis-acting repressive elements within the H19 ICR but
outside of CTCF binding sites. We analyzed the effects of two
mutations at the ICR on paternal H19 repression: (1) deletion of
sequence between CTCF binding sites 2 and 3 (H19ICR-ΔIVS), which
reduces the size of the ICR and depletes CpGs and potential binding
sites for trans-acting factors without disrupting CTCF binding sites,
and (2) CpG depletion at the ICR but outside of CTCF sites, with no
change in size of the ICR (H19ICR-8nrCG). Paternal inheritance of both
H19ICR-8nrCG and H19ICR-ΔIVS leads to loss of repression of paternal H19
indicating that the ICR acts in cis through size and CpG density,
independent of CTCF binding sites, to repress paternalH19 expression.
Materials and methods
Targeting vectors
pH19ICRΔIVSneo (Fig. 1A): Using a 2.2 kb 129/SvJ genomic fragment
containing the H19 ICR [from HindIII, −2.06 kb upstream of the H19
transcription start site (TSS) to HindIII, −4.3 kb upstream of the H19
TSS] cloned into pBluescriptIIKSM (pBSIIKSM), 0.873 kb of intervening
sequence (IVS) between CTCF sites 2 and 3 (from BglI site at −2.7 kb
and BspHI site at −3.6 kb) was deleted by Quikchange site-directed
mutagenesis (Stratagene). Primer used for site directed mutagenesis:
5′-GTGAGCCACACTGGCTGGATATCATAGATGGTGATAGGGGAG-3′ (AT
nucleotides added at site of deletion generate an EcoRV site for Southern
blot analysis to conﬁrm targeting). Deletion of IVS was conﬁrmed by
sequencingwith primers that ﬂank the deleted sequence: Primer1F, 5′-
GCAACTTCGGTCTTACCAGCCACT-3′ and Primer1R, 5′-TGCAAGGAGAC-CATGCCCTATTCTTG-3′. The fragment containing the IVS deletion was
excised from the endogenous KpnI site,−3.7 kb upstreamofH19 TSS to
the KpnI site in pBSIIKSM and inserted at a unique KpnI site of the
previously described targeting vector [TVΔDMDneo (Thorvaldsen et al.,
1998), modiﬁed to remove KpnI site in pBSIIKSM]. As described
previously (Thorvaldsenet al., 1998), the targetingvector also contained
a neomycin resistance (neor) gene cassette (for selection)ﬂanked by lox
P sites and pBSIIKSM. Informative restriction enzyme digestions
followed by agarose gel electrophoresis were used to conﬁrm accurate
insertion and orientation of the mutated fragment within the targeting
vector.
pH19ICR-8nrCGneo (Fig. 1A): A129/SvJ genomic DNA fragment span-
ning theH19 ICR [describedpreviously (Engel et al., 2004)]wasmutated
at each of the four regions indicated below using the Quikchange site-
directed mutagenesis kit (Stratagene) : GTACCTCGTGGACT[CG-NCA]
GACTC, TGGTGATTTG[CG-NGC]CTTT[CG-NGC]TAT, ACACAGCC[CG-NCT]
AGAT[CG-NCT]TCAGT, CCTTCA[CG-NCT]AT[CG-NCT]AT[CG-NCT]GTTCA
(mutations italicized). The targeting vector was generated as described
previously (Engel et al., 2004) using this mutated ICR in place of the
DMD-9CG mutation. Informative restriction enzyme digestions fol-
lowed by agarose gel electrophoresis were used to conﬁrm accurate
insertion and orientation of the mutated fragment within the targeting
vector and mutated CpGs were conﬁrmed by sequencing.
Embryonic stem (ES) cells and mouse generation
Targeting vectors were linearized and electroporated into E14.1 ES
cells (Kuhn et al., 1991) as described previously (Thorvaldsen et al.,
1998). G418-resistant positive clones were isolated and targeting to
the H19/Igf2 locus was conﬁrmed by restriction digestion followed by
Southern hybridization as described previously (Thorvaldsen et al.,
1998). Correctly targeted ES cell clones were injected into C57BL/6J
(B6) blastocysts and mice were generated by the Transgenic and
Chimeric Mouse Facility at the University of Pennsylvania. Chimeras
were obtained and mated to B6 mice. Germline transmission of the
targeted mutant alleles was conﬁrmed in the agouti progeny by DNA
isolated from tail biopsies subjected to Southern blot as described
previously (Thorvaldsen et al., 1998). All studies adhered to pro-
cedures approved by the Institutional Animal Care and Use Committee
at the University of Pennsylvania.
Mouse breeding and genotyping
Mutant mice having inherited the targeted mutations through
germline transmission were conﬁrmed by PCR based genotyping on
DNA isolated from tail biopsies using primers that ﬂank the deletion
(Primer1F and Primer1R, as described above, for the ΔIVS mutation) or
using primers that ﬂank the end of the Neor cassette (Primer2F, 5′-
CGAAGTTATTAGGTCCCTCGATCGAG-3′ and Primer2R, 5′-CACCCCAT-
GACCCTTATGAATCATTG-3′ for both the ΔIVS and 8nrCG alleles). The
neor cassette (ﬂankedby loxP sites)was excised in themouseby crossing
heterozygous mutant mice (H19ICRΔIVSneo/+ or H19ICR-8nrCGneo/+) to mice
expressing Cre recombinase under the control of the human cytomeg-
alovirus promoter on a B6 genetic background (obtained from Edward
Morissey).Neor excisionwas conﬁrmed in the progeny by Southern blot
and PCR analysis using primers that ﬂank the neor cassette, G2 (H19-
2.3F) and G5 (H19-2.0F), as described previously (Thorvaldsen et al.,
1998, 2002). Mutant lines lacking the neor cassette were maintained by
crossing to B6 and selecting for progeny carrying the mutation by PCR
analysis. To distinguish parental alleles for all allelic assays described in
this study, heterozygous mutant mice (H19ICRΔIVS/+ or H19ICR-8nrCG/+)
were crossed to B6(CAST7), also referred to as C7 mice, which are
homozygous on chromosome 7 for wild-type alleles from the Mus
musculus castaneus (CAST) strain on a mostly B6 background (Mann et
al., 2003). Mice were weighed immediately after birth to determine the
presence of abnormal growth as has been associated with loss of
Fig. 1. Generation of the at H19ICR-8nrCG and H19ICRΔIVS alleles. (A) Targeting scheme at the H19/Igf2 locus. Illustrated from top to bottom are the wild-type locus, the targeting vectors,
the correctly targeted alleles and the targeted alleles after excision of the neor selection marker. Restriction sites and their relative positions (in kb) to the H19 transcription start site
are indicated above the endogenous locus. Southern probes (A, B and C) are indicated by horizontal lines below the endogenous locus. Depicted is the endogenous sequence with the
H19 ICR (white rectangle), CTCF sites (white triangles) and H19 exons (gray rectangles). The vectors include pBluescriptIIKS sequence (bold line), neor cassette (polka dot box), loxP
sites (black arrowheads) and 129/Sv H19 DNA (thin line). The deleted sequence in the ICRΔIVS mutation is indicated by a cross-hatched region and the inserted EcoRV site (see
materials and methods) is above locus in bold and diagonal. The CpG mutations in the ICR-8nrCG mutation are indicated by black diamonds. (B) Southern blots to conﬁrm correctly
targeted alleles using external probes A — EcoRV digest (i) and B — StuI digest (ii), and internal probe C — SacI digest (iii) as previously described (Thorvaldsen et al., 2002).
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mutant mice are compared to their wild-type littermate controls.
DNA isolation and methylation analysis
DNA was isolated from neonatal liver and mature sperm as
described previously (Bartolomei et al., 1993). Methylation Southern
analysis was performed as described previously (Thorvaldsen et al.,
2002). Bisulﬁte mutagenesis was performed on liver and sperm
according to themanufacturer's protocol of theMOD50 Imprint®DNA
Modiﬁcation Kit (SIGMA-ALDRICH). For wild-type and 8nrCG bisulﬁte
converted samples, R1 and R2 were ampliﬁed as described previously
(Davis et al., 2000) using primers BMsp2t1, BMsp2t2, BHhalt4 and
BHhalt3 with the following modiﬁcation to BHhalt4 (5′-CTAACCTCA-
TAAAACCCATAACTAT-3′); and R3 was ampliﬁed using BHha5t2,
BHha5t, and BHha5t3. For ΔIVS samples R1, R2 and R3 were ampliﬁed
using primers BMsp2t1 and Primer3R1 (BUP4R) 5′-AATAAAT-
CAAATTCTCTAATTCAATATA-3′ followed by nested primer with,
BMsp2t2 and BHha5t3 (Davis et al., 2000). For wild-type, 8nrCG and
ΔIVS samples, R4 was ampliﬁed as described previously (Thorvaldsen
et al., 2002) using B8 (BTV3-1), B9 (BTV3-2), B10 (BTV3-3) and B11
(BTV3-4); and the H19 promoter proximal region was ampliﬁed as
described previously (Thorvaldsen et al., 2006) using B12 (BH19-
0.9f), B13 (BH19-0.85f) and B14 (BH19-0.5r).
RNA isolation and analysis
Total RNA was extracted from mouse tissues of various develop-
mental stages (tissues used fresh or ﬂash frozen in liquid nitrogen and
stored at−80 °C) using Trizol Reagent (Invitrogen) and by following
the manufacturer's protocol. For H19 RNase protection assay (RPA),
5 μg of RNA was used with the RPAIII RNase protection assay kit
(Ambion) followingmanufacturer's protocol. The probe was preparedand analysis performed as described previously (Thorvaldsen et al.,
1998).
For reverse transcription PCR (RT-PCR), RNA was ﬁrst DNAse
treated using RQ1 DNase (Promega) according to manufacturer's
protocol, and next reverse transcribed using Superscript III (Invitro-
gen) following manufacturer's protocol. For each RNA sample, both
negative (no transcriptase added) and positive (transcriptase added)
reactions were performed. Approximately 2.5 ng of cDNA was used
for all assays. For allele speciﬁc RT-PCR, Igf2 was ampliﬁed using
primers Igf2-18 and Igf2-20 and digested with restriction enzyme
Tsp4091, as previously described (Thorvaldsen et al., 2006). H19 was
ampliﬁed using primers HE2 and HE4 (Thorvaldsen et al., 2006),
which ampliﬁes a 235 bp fragment. Alleles were speciﬁed using a
nucleotide polymorphism between the B6 and CAST alleles that
generates a Cac8I site unique to B6. When digested with Cac8I, the
CAST allele is 235 bp while the B6 fragments were 173 bp and 62 bp.
Digested RT-PCR fragments were resolved on either 15% (Igf2) or 12%
(H19) polyacrylamide gel and band intensities were measured using
ImageJ. For quantitative (q) RT-PCR, total Igf2 levels weremeasured in
reference to Arpp0 (acidic phosphoprotein P0 subunit) as previously
described (Weaver et al., 2010).
Statistics
P-value calculated using two-tailed Student's T-test with equal
variance to compare the percent paternal H19 expression between
H19ICRΔIVS and H19ICR-8nrCG alleles shown in Fig. 2.
Results
Generation of the H19ICRΔIVS and H19ICR-8nrCG alleles
To determine the presence of cis-regulatory elements outside of
CTCF sites at the H19 ICR, mice carrying two types of mutant alleles at
Fig. 2. Expression of H19 and Igf2 in ΔIVS or 8nrCG mutant neonatal tissues. (A) Allelic H19 expression analyzed by RNase Protection Assay on neonatal liver RNA from heterozygous
littermates having a maternally inherited CAST allele and either a paternally inherited mutant (+/−) or wild-type (+/+) B6 allele. (B) Allelic H19 expression analyzed by RT-PCR
and restriction enzyme digestion using neonatal tongue cDNA from heterozygous littermates as described above. The progeny tested were generated through crosses between C7
females and heterozygousmutantmales (H19ICRΔIVS/+ orH19ICR-8nrCG/+) as indicated above panels. B6 (B) and CAST (C) controls are indicated. Arrows denote bands representative of
paternal (pat) and maternal (mat) H19 expression. The percent of H19 expression from the mutant allele in each sample is indicated below each row (%B). (C) Total Igf2 expression
assayed by qRT-PCR on neonatal liver cDNA from heterozygous mutant and wild-type littermates as described above. Igf2mean relative expression levels (n=3) are displayed and
standard deviation error bars are shown. (D) Allele speciﬁc Igf2 expression was analyzed by RT-PCR using neonatal liver cDNA from heterozygous littermates carrying a paternally
inherited CAST allele and either a maternally inherited mutant (−/+) or wild-type (+/+) B6 allele. The progeny tested were generated through crosses between heterozygous
mutant females (H19ICRΔIVS/+ or H19ICR-8nrCG/+) and C7 males as indicated above panels. Negative RT controls showed no contamination for all RT-PCRs (data not shown).
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in ES cells: H19ICRΔIVS and H19ICR-8nrCG. The sequence perturbed by
these mutations is not conserved between rodents and humans
(Frevel et al., 1999; Stadnick et al., 1999), however, the H19ICRΔIVS
deletion removes ~0.9 kb of sequence between CTCF sites 2 and 3 at
the ICR, which reduces the size of the ICR by ~50% and deletes ~35% of
the CpGs at the ICR (Fig. 1A); and the H19ICR-8nrCG allele contains
mutations in 8 CpGs across the ICR, which depletes ~16% of CpGs
without changing the size of the ICR or disrupting CTCF sites (Fig. 1A).
Two of the eight CpGs mutated in the 8nrCG mutant overlap with the
ΔIVS deletion.
Germline transmission of the targeted clones and excision of the
neor cassette in the mouse were conﬁrmed by Southern blot analysis
(Fig. 1B). Mutant progeny lacking the neor cassette were assayed for
defects in H19/Igf2 imprinting when the mutant allele was maternally
or paternally inherited. In the experiments described below, parental
origin of alleles was distinguished by crossing heterozygous mutant
mice (H19ICRΔIVS/+ or H19ICR-8nrCG/+) to wild-type C7 mice. Tissuesfrom the resulting heterozygous mutant neonatal progeny were
compared to their heterozygous wild-type littermates.
Paternal inheritance of H19ICRΔIVS and H19ICR-8nrCG mutations results in
derepression of paternal H19
To determine the effects of the ΔIVS and 8nrCG mutations on
imprinting at the H19/Igf2 locuswe assayed allelic expression by RNase
Protection Assay (RPA). Upon paternal inheritance of either H19ICRΔIVS
orH19ICR-8nrCG, paternalH19 expression, indicative of loss of imprinting,
was observed in neonatal liver (Fig. 2A) and at very low levels in tongue
(Fig. 2B). Paternal H19 levels were consistently higher [though not
always signiﬁcantly higher (p=.07 in liver, p=.01 in tongue)] in the
8nrCG mutants compared to ΔIVS (Figs. 2A and B). This aberrant
paternal H19 expression was detectable as early as E13.5 in embryonic
tissues when either mutant was paternally transmitted (Fig. 3 and data
not shown); and in extraembryonic tissues as early as E6.5 and E13.5 in
8nrCG and ΔIVS mutants, respectively (Fig. 3 and data not shown).
Fig. 3. Paternal H19 expression throughout development in ΔIVS or 8nrCG mutants. Allelic H19 expression was analyzed by RNase Protection Assay in tissues harvested at different
developmental times or tissues (as indicated). RNAwas assayed from heterozygous littermates carrying amaternally inherited (mat) CAST (C) allele and either a paternally inherited
(pat) mutant B6 (B) allele (+/−) or a paternally inherited wild-type B6 allele (+/+). The progeny tested were generated through crosses between C7 females and heterozygous
mutant males [H19ICRΔIVS/+ (A) or H19ICR-8nrCG/+ (B)] as indicated beside panels. Assay for 4-week liver is shown at normal exposure [14–24 hours (h), same as neonatal and
embryonic tissues] to demonstrate low levels of expression at this time point, and overexposure (72–96 h) to determine paternal allele expression. See legend to Fig. 2 for details on
percent allelic expression.
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when comparing wild-type and mutant (H19ICRΔIVS or H19ICR-8nrCG)
neonates within litters (data not shown). Furthermore, both qRT-PCR
andnorthern blot analysis revealednodifference in total Igf2 expression
levels in liver of mutant and wild-type littermates (Fig. 2C and data
not shown).
Aberrant paternal H19 expression observed inH19ICRΔIVS andH19ICR-8nrCG
mutants is subject to the temporally and spatially restricted expression
pattern of H19
Derepression of the paternal allele in H19ICRΔIVS and H19ICR-8nrCG
mutants is not detectable at all developmental time points and tissues
when H19 is normally expressed. Therefore, we next examined
whether the expression pattern of the mutant H19/Igf2 locus follows
the temporally restricted pattern of the wild-type locus or if a de novo
mechanism is activating the mutant locus. To this end, we ﬁrst
determined whether the level of expression of paternal H19 observed
in association with themutant ICRs is correlated with the total level of
H19 expression observed at different developmental time points.
In the mouse, H19 expression levels vary between developmental
stages. H19 is detectable as early as E3.5 in trophectoderm and E8.5 in
the embryo proper (Doherty et al., 2000; Poirier et al., 1991). Levels
steadily increase thereafter to peak around 3 days after birth and
remain high until day 9 before rapidly declining to basal levels by
day 28 (Pachnis et al., 1984). By analyzing levels of paternal H19expression in liver throughout development, we found that for both
mutations the stage of development when total H19 is expressed at
its highest level, neonatal liver (Pachnis et al., 1984), is also when
aberrant paternal H19 expression is highest (Fig. 3). Likewise, when
total H19 is at intermediate (E13.5) or very low levels (4 wks)
(Pachnis et al., 1984), aberrant paternal H19 expression in the mutant
is also at intermediate or undetectable levels (Fig. 3). These data
demonstrate that aberrant paternal H19 expression levels positively
correlate with the temporally restricted expression pattern of H19.
In addition to examining the effects of our mutations at different
developmental stages,we also analyzedH19 expression in embryonic vs.
extraembryonicmutant tissues at a singledevelopmental time (E13.5) in
comparison to wild-type littermates (Fig. 3). We observed paternal H19
derepression in all three tissues tested (E13.5 liver, placenta and yolk
sac). Interestingly, the levels of aberrant paternalH19 expression appear
more variable among extraembryonic samples (E13.5 yolk sac and
placenta) than observed among the embryonic samples (E13.5 liver)
(Fig. 3). Overall, this ﬁnding conﬁrms that the aberrant paternal H19
expression pattern associated with the ΔIVS and 8nrCG mutation
coincides with the spatially restricted expression pattern of H19.
Taken together, we conclude that the level of paternal H19
derepression associated with the H19ICR-ΔIVS and H19ICR-8nrCG mutant
alleles is dependent upon the levels of total H19 expression and is not
regulated by a de novo temporal or tissue speciﬁc mechanism. Thus,
the effects of these mutations are speciﬁcally due to a disruption in
imprinted repression of H19.
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establishment or maintenance of epigenetic modiﬁcations at the ICR or
H19 promoter
Biallelic H19 expression is often indicative of a loss of methylation
at the paternal ICR and/or H19 promoter (Engel et al., 2004;
Thorvaldsen et al., 1998). To determine whether paternal H19
methylation was perturbed by the ΔIVS or 8nrCG mutations, we
performed bisulﬁte sequencing at the ICR in neonatal liver. We
observed no signiﬁcant changes in DNA methylation at the mutant
paternal ICRs as compared to the wild-type ICRs in littermates
(Fig. 4A), demonstrating that neither mutation disrupts maintenance
of the hypermethylated paternal ICR. Next, we determined whether
thesemutations affect methylation establishment at the ICR inmature
sperm.We have previously determined that methylation around CTCF
sites 1 and 2 is representative of the entire ICR, therefore we only
investigated these regions. There was no observable defect in
hypermethylation at the paternal ICR in mutant sperm compared to
wild-type sperm (Fig. 4A).
Bisulﬁte analysis clearly demonstrates that the ΔIVS and 8nrCG
mutations do not affect hypermethylation at the ICR. However, to
determine the effects of these mutations on spreading of methylation
to the H19 promoter, we analyzed methylation at the H19 promoter
(by Southern blot analysis) and promoter proximal regions (by
bisulﬁte sequencing) in neonatal liver. Interestingly, though we did
see activation of paternalH19 in thesemutant tissues, wewere unableFig. 4.Methylation proﬁle of the paternal H19 and 5′ upstream region in neonatal liver and s
scale). CTCF sites (triangles, R1–R4) at the ICR (horizontal gray rectangle) and promoter p
paternal H19ICRΔIVS (ΔIVS) or H19ICR-8nrCG (8nrCG) alleles and wild-type (wt) paternal alleles
and mature sperm. Open and closed circles denote unmethylated and methylated cytosine
missing/undetermined sequence and asterisks (*) denote sequence deleted ormutated in the
sites or promoter proximal) indicated in above schematic. (B) Schematic of the H19 region
2002)]. The position (in base pairs) relative to the start of transcription is depicted above.
restriction sites; the polymorphic PvuII (P) site denoted by asterisks (**); and the probe us
parental alleles were differentiated by digesting genomic DNA from neonatal liver with Pvu
presence (+) or absence (−) of HpaII (H) is marked above the panels. The progeny tested a
males (H19ICRΔIVS/+ or H19ICR-8nrCG/+) as indicated above panels. The maternal (mat) CASTto detect loss of methylation as compared to wild-type littermates
either at the H19 promoter proximal region or at the H19 promoter
(Figs. 4A and B, respectively). These data demonstrate that although
both H19ICR-ΔIVS and H19ICR-8nrCG mutant alleles are able to properly
establish and maintain the hypermethylated status of the paternal
H19/Igf2 locus, imprinted H19 repression is perturbed.
Analysis of maternal transmission of H19ICRΔIVS and H19ICR-8nrCG alleles
We next assessed the effects of maternal inheritance of either the
H19ICRΔIVS or H19ICR-8nrCG alleles using allele speciﬁc RT-PCR. We
observed that both mutants properly express Igf2 monoallelically
from the paternal allele (Fig. 2D). Additionally, using bisulﬁte
mutagenesis and sequencing we found that both H19ICRΔIVS and
H19ICR-8nrCG mutant maternal alleles were properly hypomethylated
at the ICR (data not shown). No difference in weight was observed
when comparingwild-type andmutant neonatal littermates for either
mutant (data not shown). We thus conclude that maternal inheri-
tance of either mutant allele does not disrupt imprinting at the H19/
Igf2 locus.
Discussion
Genomic imprinting is a complex epigenetic phenomenon that is
an essential part of normal development. It requires that cellular
machinery ﬁrst recognize the parental origin of nearly identical allelesperm. (A) Schematic of the H19 ICR and promoter proximal region (above, not drawn to
roximal region are depicted. Illustrated below is the methylation status of the mutant
as determined by bisulﬁte mutagenesis and sequencing performed with neonatal liver
s, respectively, along a single horizontal strand of cloned DNA. Absent circles indicate
respective mutant alleles. Shaded rectangles overlay cytosines assayed in regions (CTCF
analyzed by methylation sensitive Southern blot [modiﬁed from (Thorvaldsen et al.,
Illustrated are: the endogenous H19 transcription unit and ICR (rectangles); HpaII (H)
ed (bold line below H19 transcription unit) — EcoRI (R) to StuI (St). Illustrated below,
II, StuI and HpaII (+) or with only PvuII and StuI (−). Genotypes of the sample and the
re littermates generated through crosses between C7 females and heterozygous mutant
allele is 3.4 kb and the paternal (pat) B6 allele is 3.2 kb.
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parental origin. More than 100 genes have been characterized as
imprinted. Interestingly, despite this common outcome in gene
expression, several mechanisms of imprinting have been described
(Ideraabdullah et al., 2008). These include insulators and non-coding
RNA mechanisms acting at the level of single loci, entire domains or
even at entire chromosomal regions (i.e. imprinted X chromosome
inactivation).
At most imprinted loci it is well understood that ICRs play a key
role in regulation of imprinted expression of linked genes. While
research has provided many major breakthroughs in our understand-
ing of ICR-mediated imprinting control, it is still not fully understood
how ICRs regulate imprinting. This is true especially for genes like
H19andIgf2, which are mainly regulated by the same ICR and
enhancers but are expressed from opposite parental alleles. For this
purpose, the H19/Igf2 ICR plays dual roles: (1) insulation and H19
activation on the maternal allele and (2) Igf2 repression on the
paternal allele.
Here we used two targeted mutations in the mouse, H19ICRΔIVS and
H19ICR-8nrCG, to investigate the role of sequences at the ICR that are
outside of CTCF binding sites. While these mutations had no
observable effect on the maternal allele in insulation and activation,
the mutations allowed us to speciﬁcally dissect the role of size and
CpG content at the H19 ICR in paternal H19 repression. Derepression
of paternal H19 has been shown to occur by either loss of methylation
at the paternal ICR and H19 promoter or by formation of an insulator
at an aberrantly demethylated paternal ICR (Engel et al., 2004;
Thorvaldsen et al., 1998, 2002). Surprisingly, we have found that
while we can detect aberrant paternal H19 expression in the
H19ICRΔIVS and H19ICR-8nrCG mutants, methylation at the paternal ICR
and H19 promoter is unaffected. This ﬁnding demonstrates that while
methylation at the paternal H19 promoter and ICR is required for H19
repression, it is clearly not sufﬁcient. Therefore, the ICR contains a
repressive function aside from its hypermethylated state and CTCF
binding sites. Furthermore, this novel repressive function is particu-
larly required when H19 is expressed at very high levels (Fig. 3).
The precisemechanismof this repressive function of the ICR remains
unclear; however, our ﬁndings strongly support a role for ICR size and
CpG content in repression of paternalH19. As shown in Fig. 5, the 8nrCG
mutationsdeplete ~16%of CpGs at the ICRwithout changing the ICR size
while the ΔIVS mutation decreases the ICR size by ~50% thereby
decreasing the overall number of CpGs by ~35% but actually increasing
the CpG density by ~30%. Interestingly, while both mutants show
derepression of paternal H19, we consistently observed slightly higher
levels of aberrant paternal H19 expression in H19ICR-8nrCGvs. H19ICRΔIVSFig. 5. Comparison of ICR size and CpG content of H19ICR-8nrCG, H19ICRΔIVS, H19SiLK alleles. Sy
determined by number of base pairs (bp) from the start of the 21 bp consensus CTCF site 1,−
of H19 (149, 766, 207–149, 767, 952, NCBI m37). CpG content is categorized by number of CG
dividing the number (#) of CG dinucleotides by the total number of dinucleotides; and the pe
subtracting the wild-type percent of CpGs (%) from the mutant percent of CpGs and dividin
restriction sites and their relative positions (in kb) to the H19 transcription start site are indic
in the adjacently described mutant ICR is indicated by cross-hatched regions and CpG mutamutant neonatal liver (Figs. 2A and B, and 3). We propose that the
reduced size of the ΔIVS mutant ICR causes it to be insufﬁcient for
maintaining complete repression of paternal H19, however, the higher
CpG density at the ΔIVS mutant ICR permits better maintenance of the
ICR's repressive function compared to the 8nrCGmutant ICR, which has
lowered CpG density. Thus, the size and percent of CpGs at the 8nrCG
and ΔIVS mutant ICRs are directly correlated with their ability to
maintain paternal H19 repression.
These ﬁndings elucidate a novel role of ICR-mediated repression
on the paternal allele that has long been under speculation. It is not,
however, conclusive whether ICR size and CpG content are the only
repressive cis-acting elements at the ICR required for paternal H19
repression. For example, the involvement of CTCF sites at the ICR in
paternal H19 repression also remains in question. Though numerous
mutations have been made and characterized at the endogenous H19
ICR, the role of ICR size and CpG content could not be determined as all
previous mutations that reduce CpG content or ICR size simulta-
neously perturbed CTCF binding sites. Previously, Drewell and
colleagues reported the presence of a 1.2 kb silencer element at the
distal end of the H19 ICR that is required for paternal H19 repression
(Drewell et al., 2000). However, the repressive function of this
silencer element at the endogenous mouse locus remains uncertain
due to the fact that initial studies characterizing this element were
performed in Drosophila (Lyko et al., 1997) and later studies
determined that a Drosophila speciﬁc factor, Su (Hw), regulates the
silencer activity (Schoenfelder and Paro, 2004). Interestingly, analo-
gous to our mutants, targeted deletion of this silencer element
(H19SilK) at the paternalH19 ICR also signiﬁcantly reduces the number
and density of CpGs (Fig. 5) and resulted in derepression of paternal
H19without a change in DNA hypermethylation at the remaining ICR
sequence (Drewell et al., 2000). It is important to note that the ΔIVS
mutation overlaps this silencer element by only ~300 bp (~25% of the
silencer element size, Fig. 5). The 8nrCG mutations overlap the
silencer element mutation at 5 bp and overlap the ΔIVS mutation at
4 bp (Fig. 5). Additionally, no sequence mutations are common to the
three mutants (Fig. 5). Thus, although the mutated regions differ
greatly among the threemutants (H19SilK,H19ICRΔIVS andH19ICR-8nrCG),
paternal H19 repression is signiﬁcantly disrupted in all three, arguing
against the presence of a single speciﬁc repressive element at the ICR.
These data strongly imply that it is not a particular region of the
ICR (binding/other site) that harbors repressive elements but rather
the overall size of the ICR and CpG density that play a signiﬁcant role
in repression of paternal H19. Though it can be argued that the 8nrCG
and ΔIVS mutations may have disrupted binding of repressors or
created a binding site for an activator, we do not believe this to be thembol @ denotes reference for H19SiLK allele (Drewell et al., 2000). ICR size is shown as
3.9 kb upstream ofH19, to the end of the 21 bp consensus CTCF site 4,−2.2 kb upstream
dinucleotides within the ICR described above (#); the percent of CpGs (%) calculated by
rcent change in CpG density between themutant andwild-type ICRs (%Δ) calculated by
g the ﬁnal value by the wild-type percent of CpGs. The ICR is depicted for each allele:
ated above the endogenous locus, CTCF sites are denoted by triangles, deleted sequence
tions are indicated by asterisks.
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likely to mediate repression for two reasons. First, other than CTCF
sites, sequence at the ICR is poorly conserved among species (Frevel et
al., 1999; Stadnick et al., 1999) and second, several attempts (through
chromatin immunoprecipitation, DNA footprinting, etc.) to identify
repressive factors that bind to the paternal H19 ICR have returned few
and unclear results (Reese et al., 2007; Szabo et al., 2000). Moreover,
while it is also possible that these mutations have created binding
sites for activators, this too is also unlikely due to the fact that several
different types of mutations (deletions and point mutations) made in
different regions of the ICR with very little sequence overlap have
produced a similar loss of paternal H19 repression.
The size and CpG content at the H19 ICR varies widely among
species. For example, the human H19 ICR (imprinting center 1, IC1) is
twice as large as the mouse (~5 kb vs. ~2 kb, respectively) and
contains more than three times as many CpGs. It would be interesting
to determine whether the differences in ICR size and CpG density
between species is correlated to differences in the level of imprinted
repressive function of the ICR. It will also be important to determine
whether there is a speciﬁc effective size and CpG density that are
sufﬁcient for paternal H19 repression and whether these two factors
are equally important. In other words, is there a certain threshold for
ICR size or CpG density that is sufﬁcient to maintain repression or is it
additive such that the level of repression is positively correlated with
the ICR size and CpG density? Although further experiments are
required, our data suggest the latter, an additive mechanism that is
dependent on the size of the ICR and the density of CpGs therein.
Our studies further clarify the previously elusive repressive function
of the H19/Igf2 ICR, however, the speciﬁc factors responsible remain
unknown. Of relevance, methyl-binding domain proteins, MeCP2 and
MBD3, have been implicated in imprinting regulation at H19/Igf2
(Drewell et al., 2002; Reese et al., 2007). It is likely that in addition to
inhibiting binding of the activator/insulator CTCF, the repressive
function of methylation at the H19/Igf2 ICR also includes recruitment
of repressive methyl-binding proteins. Therefore, even though changes
in the paternal ICR size or subtle changes to CpG density (such as those
causedby the 8nrCGmutation)maynot be sufﬁcient to cause signiﬁcant
defects in hypermethylation at the paternal ICR, they may be sufﬁcient
to disrupt/alter binding of repressive factors such as methyl-binding
proteins. Furthermore, a decrease in recruitment or binding of methyl-
binding domain proteins may allow for a loosening of local chromatin
which could potentially explain the derepression of paternal H19
observed in this study. Further studies to examine just howCpGdensity,
size of methylated ICRs, repressive protein complexes and local
chromatin structure work together to cause repression at imprinted
loci may have a wider implication in the repressive role of CpG clusters
genome-wide.
In addition to exploring the mechanism of the repressive function
of the H19 ICR, these studies highlight the importance of studying the
effects of subtle genetic perturbations in disease etiology. While most
studies of SRS have identiﬁed epimutations at the IC1 as the major
cause of defects in paternalH19 repression associatedwith the disease
(Bartholdi et al., 2009; Begemann et al., 2010; Gicquel et al., 2005); the
8nrCGmutant presented here suggests that single base pair mutations
may also play a key role in aberrant transcriptional regulation at the
H19/Igf2 imprinted locus. It is, however, likely that in the case of such
subtle genetic changes, secondary genetic/epigenetic mutations or
human exposure to environmental factors may be required to cause
the increased phenotypic effects associatedwith the disease state. This
may also be relevant for larger genetic mutations. Interestingly, the
ΔIVS mutation described here, which deletes previously identiﬁed
Oct-binding sequences (Hori et al., 2002) that are conserved in
humans and recently found to be mutated in BWS patients (Demars
et al., 2010), does not affect imprinting at the locus when maternally
inherited. This ﬁnding suggests that either the Oct-binding sequences
are unimportant for ICR function on the maternal allele in the mouseand possibly in humans, or that additional perturbation of the genome
(environmental or other) is required for loss of imprinting at the H19/
Igf2 locus. Further studies that combine mutant models or include
environmental perturbation may be necessary to generate more
analogous mouse models of human diseases such as SRS and BWS.
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